Liaoning Chengda Biotechnology Co (SHSE:688739) Other Net Income (Loss) : ¥-0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Liaoning Chengda Biotechnology Co Other Net Income (Loss)?

Liaoning Chengda Biotechnology Co's Other Net Income (Loss) for the three months ended in Mar. 2025 was ¥0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-0 Mil.

Liaoning Chengda Biotechnology Co's quarterly Other Net Income (Loss) declined from Sep. 2024 (¥0 Mil) to Dec. 2024 (¥-0 Mil) but then increased from Dec. 2024 (¥-0 Mil) to Mar. 2025 (¥0 Mil).

Liaoning Chengda Biotechnology Co Other Net Income (Loss) Historical Data

The historical data trend for Liaoning Chengda Biotechnology Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Liaoning Chengda Biotechnology Co Other Net Income (Loss) Chart

Liaoning Chengda Biotechnology Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Net Income (Loss)

Get a 7-Day Free Trial

Liaoning Chengda Biotechnology Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Liaoning Chengda Biotechnology Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0 Mil.

Liaoning Chengda Biotechnology Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Liaoning Chengda Biotechnology Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Liaoning Chengda Biotechnology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Liaoning Chengda Biotechnology Co Ltd (SHSE:688739) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Xinfang Street, Hunnan New District, Liaoning Province, Shenyang, CHN, 110179

Website

http://www.cdbio.cn

Liaoning Chengda Biotechnology Co Ltd is engaged in the research and development, production and sales of human vaccines.

Executives

Li Ning	Director
Cui Jian Wei	senior management
Chen Xin	senior management
Zhang Shu Min	Director
Zhou Li Bao	senior management
Yuan De Ming	senior management
Gao Jun	Director
Yang Xu	Director

Liaoning Chengda Biotechnology Co Headlines

No Headlines